Yakugai AIDS and the Yokohama Xth international AIDS conference. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Yakugai AIDS and the Yokohama Xth international AIDS conference. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Common Factor. 1995 Apr;(no 10):1, 22. Unique Identifier : AIDSLINE AIDS/95700360
Haas GJ

Abstract: The Tenth International AIDS Conference focused on groups who often receive less attention: Asians, women, and persons with hemophilia. The conference revealed that there is a worldwide leveling of the male/female ratio of HIV infections, showing that transmission is now predominantly heterosexual and through IV drug use. Very little was discussed about women's health and treatment needs. Several men and adolescents with hemophilia/HIV infection from the Japanese hemophilia community shared their personal stories. A highlight of the conference was Yoshiaki Ishida's presentation, who described the conditions of HIV-infected persons with hemophilia living in Japan. While 1985 saw the first announced AIDS case in Japan, 40 percent of the hemophilia population were already infected. Because antihemophilic factor (AHF) concentrates were imported from the United States into Japan between 1972-85, several lawsuits have been initiated, citing Japanese law prohibiting the importation of any drugs which are or are likely to be contaminated by pathogenic microorganisms. The conference ended without addressing any important treatments or discussions about alternative therapies. A unifying theme did arise against the prevailing discriminatory travel restrictions for HIV-positive persons.

Keywords: *Acquired Immunodeficiency Syndrome/COMPLICATIONS/EPIDEMIOLOGY/ TRANSMISSION Adolescence Adult Africa South of the Sahara/EPIDEMIOLOGY Asia/EPIDEMIOLOGY Female Hemophilia/*COMPLICATIONS/EPIDEMIOLOGY Human Japan/EPIDEMIOLOGY Jurisprudence Male NEWSLETTER ARTICLE

951130
M95B0905

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .